Biohaven Ltd

Biohaven Ltd

BHVN

Market Cap$1.44B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Biohaven LtdBiohaven Ltd-1.6--342%-0.2
$58.50

Target Price by Analysts

314.6% upsideBiohaven Ltd Target Price DetailsTarget Price
$0.69

Current Fair Value

95.1% downside

Overvalued by 95.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.44 Billion
Enterprise Value$1.39 Billion
Dividend Yield$0 (0%)
Earnings per Share$-9.28
Beta3.64
Outstanding Shares101,943,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-1.62
PEG-6.88
Price to Sales-
Price to Book Ratio7.06
Enterprise Value to Revenue-
Enterprise Value to EBIT-1.51
Enterprise Value to Net Income-2
Total Debt to Enterprise0.04
Debt to Equity0.19

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Biohaven Pharmaceutical Holding Company Ltd

CEO: Vlad Coric